Share
31 Posts.
lightbulb Created with Sketch. 1
clock Created with Sketch. 12/01/18
10:29
Share
Originally posted by thymus
↑
Pfizer has announced that it is pulling out of early-stage research into Alzheimer’s and Parkinson’s disease after investing heavily in the area in recent years.BMJ , Pfizer has invested heavily in Alzheimer’s research, but a succession of candidate drugs have failed in trials — including bapineuzumab, a joint venture with Johnson and Johnson, and more recently a drug known as PF-05212377.BMJ also reports that Axovant, a small company developing a drug called inteperdine with the same target as PF-05212377, announced this week that it too failed to meet its primary endpoint and further development was being abandoned.
Expand
Yes makes you wonder why they only said early stage development . Considering the the stage acw is at already. Hopefully there is something to read between the lines.
